ATE375351T1 - Verfahren zur herstellung von topotecan aus 10- hydroxy-4-(s) camtothecin - Google Patents

Verfahren zur herstellung von topotecan aus 10- hydroxy-4-(s) camtothecin

Info

Publication number
ATE375351T1
ATE375351T1 AT03719080T AT03719080T ATE375351T1 AT E375351 T1 ATE375351 T1 AT E375351T1 AT 03719080 T AT03719080 T AT 03719080T AT 03719080 T AT03719080 T AT 03719080T AT E375351 T1 ATE375351 T1 AT E375351T1
Authority
AT
Austria
Prior art keywords
topotecan
hydroxy
camtothecin
producing
dihalomethanes
Prior art date
Application number
AT03719080T
Other languages
English (en)
Inventor
Satish Puri
Geeta Handa
Kanaya Dhar
Om Suri
Ghulam Qazi
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Application granted granted Critical
Publication of ATE375351T1 publication Critical patent/ATE375351T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
AT03719080T 2003-03-31 2003-03-31 Verfahren zur herstellung von topotecan aus 10- hydroxy-4-(s) camtothecin ATE375351T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000108 WO2004087715A1 (en) 2003-03-31 2003-03-31 Process for preparing topotecan from 10-hydroxy-4-(s) camptothecin

Publications (1)

Publication Number Publication Date
ATE375351T1 true ATE375351T1 (de) 2007-10-15

Family

ID=33104957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03719080T ATE375351T1 (de) 2003-03-31 2003-03-31 Verfahren zur herstellung von topotecan aus 10- hydroxy-4-(s) camtothecin

Country Status (7)

Country Link
EP (1) EP1608660B1 (de)
JP (1) JP4477510B2 (de)
CN (1) CN100372854C (de)
AT (1) ATE375351T1 (de)
AU (1) AU2003223109A1 (de)
DE (1) DE60316849T2 (de)
WO (1) WO2004087715A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7977483B2 (en) * 2007-04-11 2011-07-12 Scinopharm Taiwan, Ltd. Process for making topotecan
CN101555250B (zh) * 2009-05-19 2011-05-18 重庆泰濠制药有限公司 盐酸拓扑替康的制备方法
ES2373172B1 (es) * 2010-07-16 2012-12-10 Consejo Superior De Investigaciones Científicas (Csic) Proceso de obtención de derivados solubles en agua de 20 (s) camptotecina como agentes antitumorales.
RU2447076C1 (ru) * 2010-12-09 2012-04-10 Закрытое Акционерное Общество "Фарм-Синтез" Способ получения топотекана

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
WO1992005785A1 (en) * 1990-09-28 1992-04-16 Smithkline Beecham Corporation Water soluble camptothecin analogues, processes and methods

Also Published As

Publication number Publication date
EP1608660B1 (de) 2007-10-10
CN1764663A (zh) 2006-04-26
JP2006514971A (ja) 2006-05-18
DE60316849D1 (de) 2007-11-22
JP4477510B2 (ja) 2010-06-09
EP1608660A1 (de) 2005-12-28
CN100372854C (zh) 2008-03-05
AU2003223109A1 (en) 2004-10-25
DE60316849T2 (de) 2008-07-17
WO2004087715A1 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
EP1378505A4 (de) Verfahren zur synthese von mit camptothecin verwandten verbindungen
SE0001438D0 (sv) New chemical compounds and their use in therapy
WO2005104711A8 (en) Purification of progesterone receptor modulators
WO2003016282A3 (en) Substituted 1h-dihydropyrazoles, their preparation and use
RS99804A (en) Novel compounds and their use
DE502004005119D1 (de) Verfahren zur Herstellung von TCD-Alkohol DM
DE602004005323D1 (de) Azidfreies verfahren zur herstellung von 1,2-diaminoverbindungen
DE60202958D1 (de) Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten
JO2616B1 (ar) مركبات ثلاثية الحلقات جديدة، طريقة من أجل تحضيرها ومركباتها الصيدلانية
ATE517622T1 (de) Salz eines tetrahydropyranylcyclopentyltetrahydropyridopyr diderivats als ccr-2 antagonisten
DE60115358D1 (de) Geformter Katalysator zur Herstellung von Triethylendiamin, Verfahren zu dessen Herstellung, und Verfahren zur Herstellung von Triethylendiamin
DE60202603D1 (de) 8-(c-beta-d-glucopyranosyl)-7,3',4'-trihydroxyflavone, verfahren zur isolation aus pterocarpus marsupium und pharmazeutische zusammensetzung zur behandlung von diabetes
ATE375351T1 (de) Verfahren zur herstellung von topotecan aus 10- hydroxy-4-(s) camtothecin
CN101005840A (zh) 制备喜树碱衍生物及其新中间体和化合物的方法
DE602005023028D1 (de) VERFAHREN ZUR HERSTELLUNG VON 11-(4-Ä2-(2-HYDROXYETHOXY)ETHYLÜ-1-PIPERAZINYL)DIBENZOÄb,fÜÄ1,4ÜTHIAZEPIN
DE602005011888D1 (de) Verfahren zur Herstellung eines einbügelbaren Einlagestoffs, sowie dadurch hergestellter Einlagestoff
ATE415404T1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
ATE404282T1 (de) Verfahren zur herstellung von kationischen rhodiumkomplexen
DE60006111D1 (de) Aluminosiloxanverbindungen und verfahren zu ihrer herstellung
DE602004017838D1 (de) Verfahren zur herstellung von 6-ä(4,5-dihydro-1h-imidazol-2-yl)amino-ü-7-methyl-1h-benzimidazol-4-carbonitrile und dessen bevorzugte salzform
JP2004538278A5 (de)
ATE300534T1 (de) Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
ATE255139T1 (de) Verfahren zur reinigung von aromatischen polyethern
DE602004031727D1 (de) Neues verfahren und zwischenprodukte zur herstellung von 19-nor-steroiden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties